双侧上尿路尿路上皮癌危险因素的研究进展
摘要
上尿路的尿路上皮癌(upper tract urothelial carcinoma,UTUC)单侧发病多见,双侧发病较为少见,可能具有一些特定的危险因素。本文从马兜铃酸、非那西丁、膀胱癌史和遗传性非息肉病性结直肠癌等角度综述了双侧UTUC发病的危险因素,以期引起泌尿外科医师的注意,尤其在诊治、随访具有这些危险因素的患者时需警惕双侧UTUC的可能性。
出处
《现代泌尿外科杂志》
CAS
2016年第2期156-158,共3页
Journal of Modern Urology
基金
上海市医学重点专科基金(No.ZK2012A22)
参考文献13
-
1SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012 [J]. CA Cancer J Clin, 2012, 62(1) 10-29.
-
2HOLMANG S, JOHANSSON S L. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome [J]. Cancer, 2004, 101(4): 741-747.
-
3HOLM,NG S, JOHANSSON S L. Bilateral metachronous ore- teral and renal pelvic carcinomas: incidence, clinical presenta- tion, histopathology, treatment and outcome [J]. ] Urol, 2006, 175(1) : 69-73.
-
4ROUPR]T M, BABJUK M, COMPIRAT E, et al. European guidelines on upper tract urothelial carcinomas.. 2013 update [J]. Eur Urol, 2013, 63(6): 1059-1071.
-
5肖荆,张玉海.马兜铃酸与肾移植患者术后并发尿路上皮癌关系及Ras、P53基因突变影响的研究[J].现代泌尿外科杂志,2011,16(5):480-482. 被引量:3
-
6WANG SM, LAI MN, WEI A, et al. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of c0ntaining aristolochic acid [J]. PLoS One, 2014, 9(8): e105218.
-
7AYDIN S, DEKAIRELLE AF, AMBROISE J, et al. Unambigu- ous detection of multiple TP53 gene mutations in AAN-associated urothelial eaneer in Belgium using laser capture microdissection [J]. PLoS One, 2014, 9(9) : e106301.
-
8POON SL, PANG ST, MCPHERSON JR, et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool [J]. Sei Transl Med, 2013,197(5) :101.
-
9CHEN CH, DICKMAN KG, HUANG CY, et al. Aristoloehic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes [J]. Int J Cancer, 2013, 133 (1) : 14-20.
-
10ANTONI S, SOERJOMATARAM I, MOORE S, et al. The ban on phenacetin is associated witb changes in the incidence trends of upper-urinary tract cancers in Australia [J]. Aust N Z J Public Health, 2014, 38(5).. 455-458.
二级参考文献16
-
1LEMY A, WISSING KM, RORIVE S, et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end- stage aristolochic acid nephropathy., a case series with 15-year follow-up[J]. Am J Kidney Dis, 2008,52(3) :630.
-
2DEBELLE FD, VANHERWEGHEM JL, NORTIER JL, et al. Aristolochic acid nephropathy: a worldwide problem[J]. Kidney Int,2008,4(2) :158-169.
-
3MARIA L, SARAH L, HOCKLEY TS, et al. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53 [J]. Toxicoi and Appl Pharmacol, 2008, 2(3):86-98.
-
4SIVAPRASAD A, RADHA RB, YANG IY, et al. DNA adducts of aristolochic acid II : total synthesis and site-specific mutagenesis studies in mammalian cells[J]. Nucleic Acids Res, 2010, 38, (1):339-352.
-
5NADIYA B, VOLKER M A, ANDREW B, et al. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy [J].Toxicology,2009, 264(1) :74-79.
-
6ZHANG X, REN L, ZHANG Y, et al. Gene profiling of cyclosporin-enhanced transitional cell carcinoma in rat model [J]. Transpl Proc,2009,4l(10):4369-4372.
-
7KATSUHIRO Y, TAKAOMI T,MASAMI K, et al. Simple and rapid analysis of aristolochic acid contained in crude drugs and Kampo formulations with solid-phase extraction and HPLC photodiode-array detection [J]. J Nat Med, 2009, 63 (4): 451-458.
-
8ABOEL DA, SMITH NW, MARLIN N, et al. Determination of Aristolochic Acid I and II in Traditional Chinese Medicine by HPCE with Label Free Intrinsic Imaging[J].Chromatographia, 2009, 70(3):467-473.
-
9CHAN W, POON WT, CHAN YW,et al. A new approach for the sensitive determination of DNA adduct of aristolochic acid II by using high-performance liquid chromatography with fluorescence detection [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci, 2009,877 (10) : 848-852.
-
10CHAN W, YUE H, POON WT, et al. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry[J].Mutat Res, 2008,646 (1) : 17-24.
共引文献2
-
1王超,李涛,张健,刘芬,解泽林,唐雅望,孙雯,郭洪波,林俊,张磊,田野,马麟麟.中国肾移植术后并发恶性肿瘤趋势分析[J].器官移植,2015,6(3):169-173. 被引量:12
-
2陈蓉,贠丹丹,黄文峰,柴艳梅,刘丹,陈群,周成.马兜铃酸诱导TM3小鼠睾丸间质细胞凋亡机制[J].陕西中医,2021,42(7):819-822. 被引量:2
-
1周利群,李学松,熊耕砚.中国人群上尿路尿路上皮癌新进展[J].北京大学学报(医学版),2014,46(4):504-506. 被引量:44
-
2王涛,陈明.肾细胞癌与VHL基因突变的研究进展[J].东南大学学报(医学版),2015,34(3):433-435. 被引量:3
-
3杨江根,江洪涛.小肾癌治疗现状及进展[J].临床泌尿外科杂志,2005,20(8):504-505. 被引量:3
-
4P.Meister,H.Garnerus,J.Stahl,阮幼冰.“镇痛剂肾脏”时一例肾盂癌的暴发性转移[J].德国医学,1995,12(3):183-185.
-
5胡青,吕伯东.恶性生物学行为肾血管平滑肌脂肪瘤(附2例报告)[J].临床医学,2007,27(4):58-58.
-
6李涛,崔惠勤.腮腺腺淋巴瘤的MRI诊断[J].临床和实验医学杂志,2012,11(12):920-921. 被引量:4
-
7阮征,李耀俊,忻文雷,王磊,黄远亮.腮腺腺淋巴瘤MRI及临床分析[J].口腔颌面外科杂志,2009,19(6):415-417. 被引量:2
-
8李洁,吴晶涛,蒋记心,陈文新,王守安,叶靖,朱庆强.原发性输卵管癌九例[J].中华全科医师杂志,2013,12(5):399-400.
-
9钱仲余,钱利明,袁文斌,张原原,张惠峰.卵巢浆液性囊腺瘤的CT诊断与鉴别诊断[J].中国实用医药,2010,5(3):117-118. 被引量:4
-
10程南生.听神经瘤的CT诊断和鉴别诊断[J].安徽医学,2006,27(2):151-152. 被引量:1